Adult Nodular Sclerosis Hodgkin Lymphoma Completed Phase 1 / 2 Trials for Bendamustine (DB06769)

IndicationStatusPhase
DBCOND0030887 (Adult Nodular Sclerosis Hodgkin Lymphoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01535924Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's LymphomaTreatment